Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2006 1
2007 2
2008 5
2009 4
2010 7
2011 9
2012 7
2013 7
2014 11
2015 17
2016 9
2017 9
2018 6
2019 4
2020 11
2021 7
Text availability
Article attribute
Article type
Publication date

Search Results

101 results
Results by year
Filters applied: . Clear all
Page 1
Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized Trial.
Gheorghiade M, Greene SJ, Butler J, Filippatos G, Lam CS, Maggioni AP, Ponikowski P, Shah SJ, Solomon SD, Kraigher-Krainer E, Samano ET, Müller K, Roessig L, Pieske B; SOCRATES-REDUCED Investigators and Coordinators. Gheorghiade M, et al. JAMA. 2015 Dec 1;314(21):2251-62. doi: 10.1001/jama.2015.15734. JAMA. 2015. PMID: 26547357 Clinical Trial.
The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
Mortensen SA, Rosenfeldt F, Kumar A, Dolliner P, Filipiak KJ, Pella D, Alehagen U, Steurer G, Littarru GP; Q-SYMBIO Study Investigators. Mortensen SA, et al. Among authors: alehagen u. JACC Heart Fail. 2014 Dec;2(6):641-9. doi: 10.1016/j.jchf.2014.06.008. Epub 2014 Oct 1. JACC Heart Fail. 2014. PMID: 25282031 Free article. Clinical Trial.
Still reduced cardiovascular mortality 12 years after supplementation with selenium and coenzyme Q10 for four years: A validation of previous 10-year follow-up results of a prospective randomized double-blind placebo-controlled trial in elderly.
Alehagen U, Aaseth J, Alexander J, Johansson P. Alehagen U, et al. PLoS One. 2018 Apr 11;13(4):e0193120. doi: 10.1371/journal.pone.0193120. eCollection 2018. PLoS One. 2018. PMID: 29641571 Free PMC article. Clinical Trial.
Selenium - a trace element of clinical significance.
Alexander J, Alehagen U, Aaseth JO. Alexander J, et al. Among authors: alehagen u. Tidsskr Nor Laegeforen. 2020 Nov 23;140(17). doi: 10.4045/tidsskr.20.0675. Print 2020 Nov 24. Tidsskr Nor Laegeforen. 2020. PMID: 33231404 Free article. English, Norwegian. No abstract available.
Chromogranin A as a biomarker in cardiovascular disease.
Goetze JP, Alehagen U, Flyvbjerg A, Rehfeld JF. Goetze JP, et al. Among authors: alehagen u. Biomark Med. 2014;8(1):133-40. doi: 10.2217/bmm.13.102. Biomark Med. 2014. PMID: 24325234 Review.
Making sense of chromogranin A in heart disease.
Goetze JP, Alehagen U, Flyvbjerg A, Rehfeld JF. Goetze JP, et al. Among authors: alehagen u. Lancet Diabetes Endocrinol. 2013 Sep;1(1):7-8. doi: 10.1016/S2213-8587(13)70035-4. Epub 2013 Jun 13. Lancet Diabetes Endocrinol. 2013. PMID: 24622255 Review. No abstract available.
101 results